Published in Am J Psychiatry on February 01, 2011
Coil design considerations for deep transcranial magnetic stimulation. Clin Neurophysiol (2013) 2.78
Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2014) 2.02
Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry (2012) 1.83
Rules ventral prefrontal cortical axons use to reach their targets: implications for diffusion tensor imaging tractography and deep brain stimulation for psychiatric illness. J Neurosci (2011) 1.76
Preclinical studies modeling deep brain stimulation for depression. Biol Psychiatry (2012) 1.62
Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology (2012) 1.38
Ketamine for treatment-resistant unipolar depression: current evidence. CNS Drugs (2012) 1.38
Interoceptive predictions in the brain. Nat Rev Neurosci (2015) 1.36
Pleasure systems in the brain. Neuron (2015) 1.34
Neuromodulation for treatment-refractory major depressive disorder. CMAJ (2013) 1.29
Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers. Neuroimage (2011) 1.26
Transcranial magnetic stimulation modulates the brain's intrinsic activity in a frequency-dependent manner. Proc Natl Acad Sci U S A (2011) 1.17
Neural mechanisms of impaired fear inhibition in posttraumatic stress disorder. Front Behav Neurosci (2011) 1.13
Deep brain stimulation for treatment-resistant depression: systematic review of clinical outcomes. Neurotherapeutics (2014) 1.12
Reduced neural activation during an inhibition task is associated with impaired fear inhibition in a traumatized civilian sample. Cortex (2012) 1.11
Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest (2013) 1.07
Deep brain stimulation of the human reward system for major depression--rationale, outcomes and outlook. Neuropsychopharmacology (2014) 1.06
Pretreatment brain states identify likely nonresponse to standard treatments for depression. Biol Psychiatry (2013) 1.05
Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord (2012) 1.04
Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adherence (2012) 1.01
Classification of behaviorally defined disorders: biology versus the DSM. J Autism Dev Disord (2014) 1.01
Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. J Am Acad Child Adolesc Psychiatry (2013) 0.99
Where in the brain is depression? Curr Psychiatry Rep (2012) 0.97
Mechanisms of deep brain stimulation. J Neurophysiol (2015) 0.93
Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling. Transl Psychiatry (2013) 0.91
Mapping the "Depression Switch" During Intraoperative Testing of Subcallosal Cingulate Deep Brain Stimulation. JAMA Neurol (2015) 0.91
Pre-frontal control of closed-loop limbic neurostimulation by rodents using a brain-computer interface. J Neural Eng (2014) 0.90
Double-blind optimization of subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. J Psychiatry Neurosci (2013) 0.89
Deep-Brain Stimulation for Basal Ganglia Disorders. Basal Ganglia (2011) 0.89
Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology (2012) 0.89
Brain grey matter volume alterations in late-life depression. J Psychiatry Neurosci (2014) 0.88
Short latency activation of cortex by clinically effective thalamic brain stimulation for tremor. Mov Disord (2012) 0.86
Acute changes in mood induced by subthalamic deep brain stimulation in Parkinson disease are modulated by psychiatric diagnosis. Brain Stimul (2014) 0.86
Current perspectives on deep brain stimulation for severe neurological and psychiatric disorders. Neuropsychiatr Dis Treat (2015) 0.85
Fluoxetine prevents development of an early stress-related molecular signature in the rat infralimbic medial prefrontal cortex. Implications for depression? BMC Neurosci (2012) 0.85
Chronic depression as a model disease for cerebral aging. Dialogues Clin Neurosci (2013) 0.84
Effects of subcallosal cingulate deep brain stimulation on negative self-bias in patients with treatment-resistant depression. Brain Stimul (2014) 0.84
Deep brain stimulation. Interv Neurol (2013) 0.84
Novel applications of deep brain stimulation. Surg Neurol Int (2012) 0.83
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry (2016) 0.83
Different patterns of local field potentials from limbic DBS targets in patients with major depressive and obsessive compulsive disorder. Mol Psychiatry (2014) 0.83
Deep brain stimulation of the antero-medial globus pallidus interna for Tourette syndrome. PLoS One (2014) 0.82
Somatic treatments for mood disorders. Neuropsychopharmacology (2011) 0.82
The amygdala as a target for behavior surgery. Surg Neurol Int (2012) 0.80
Electrical stimulation alleviates depressive-like behaviors of rats: investigation of brain targets and potential mechanisms. Transl Psychiatry (2015) 0.80
Deep brain stimulation in the treatment of depression. Dialogues Clin Neurosci (2014) 0.79
Deep brain stimulation for treatment-resistant depression. Am J Psychiatry (2011) 0.79
High-frequency stimulation of the medial prefrontal cortex decreases cellular firing in the dorsal raphe. Eur J Neurosci (2015) 0.79
Astroglial Control of the Antidepressant-Like Effects of Prefrontal Cortex Deep Brain Stimulation. EBioMedicine (2015) 0.79
Ventromedial prefrontal cortex stimulation enhances memory and hippocampal neurogenesis in the middle-aged rats. Elife (2015) 0.79
Mechanisms underlying the antidepressant response and treatment resistance. Front Behav Neurosci (2014) 0.78
Neuromodulation therapies and treatment-resistant depression. Med Devices (Auckl) (2012) 0.78
A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention. J Psychiatry Neurosci (2015) 0.78
Case report: stimulation of the right amygdala induces transient changes in affective bias. Brain Stimul (2014) 0.78
Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception. AJOB Prim Res (2011) 0.78
Characterizing the therapeutic response to deep brain stimulation for treatment-resistant depression: a single center long-term perspective. Front Integr Neurosci (2015) 0.77
Treatment-resistant Late-life Depression: Challenges and Perspectives. Curr Neuropharmacol (2015) 0.77
Chronic deep brain stimulation of the medial forebrain bundle reverses depressive-like behavior in a hemiparkinsonian rodent model. Exp Brain Res (2015) 0.77
An active inference theory of allostasis and interoception in depression. Philos Trans R Soc Lond B Biol Sci (2016) 0.76
Neuromodulation for treatment-resistant depression. F1000 Med Rep (2012) 0.76
Positive Emotional Learning Induces Resilience to Depression: A Role for NMDA Receptor-mediated Synaptic Plasticity. Curr Neuropharmacol (2017) 0.76
Update on Neuromodulation for Treatment-Resistant Depression. F1000Res (2015) 0.76
Affective Brain-Computer Interfaces As Enabling Technology for Responsive Psychiatric Stimulation. Brain Comput Interfaces (Abingdon) (2014) 0.76
The Co-evolution of Neuroimaging and Psychiatric Neurosurgery. Front Neuroanat (2016) 0.76
From Engrams to Pathologies of the Brain. Front Neural Circuits (2017) 0.75
Microfabricated polymer-based neural interface for electrical stimulation/recording, drug delivery, and chemical sensing--development. Conf Proc IEEE Eng Med Biol Soc (2013) 0.75
Use of deep brain stimulation for major affective disorders. Exp Ther Med (2016) 0.75
A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice. J Physiol (2015) 0.75
Alterations of Intrinsic Brain Connectivity Patterns in Depression and Bipolar Disorders: A Critical Assessment of Magnetoencephalography-Based Evidence. Front Psychiatry (2017) 0.75
Computational Modeling and Neuroimaging Techniques for Targeting during Deep Brain Stimulation. Front Neuroanat (2016) 0.75
[Surgery for behavioral disorders: the state of the art]. Surg Neurol Int (2014) 0.75
Cortico-Striatal-Thalamic Loop Circuits of the Salience Network: A Central Pathway in Psychiatric Disease and Treatment. Front Syst Neurosci (2016) 0.75
Light up your life: optogenetics for depression? J Psychiatry Neurosci (2014) 0.75
Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study. BMC Psychiatry (2015) 0.75
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord (2015) 0.75
Analysis of gene expression changes in the rat hippocampus after deep brain stimulation of the anterior thalamic nucleus. J Vis Exp (2015) 0.75
Deep brain stimulation for psychiatric disorders: Is there an impact on social functioning? Surg Neurol Int (2017) 0.75
Physiological properties of brain-machine interface input signals. J Neurophysiol (2017) 0.75
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
Deep brain stimulation for treatment-resistant depression. Neuron (2005) 12.39
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain (2007) 4.13
Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry (2013) 4.12
Mechanisms of deep brain stimulation. Mov Disord (2002) 3.91
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A (2005) 3.83
A whole brain fMRI atlas generated via spatially constrained spectral clustering. Hum Brain Mapp (2011) 3.75
Neurobiological mechanisms of the placebo effect. J Neurosci (2005) 3.41
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2011) 3.30
Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: a phase 1 pilot trial. Lancet (2013) 3.21
Dependence of subthalamic nucleus oscillations on movement and dopamine in Parkinson's disease. Brain (2002) 3.15
Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2008) 3.00
A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain (2008) 2.65
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64
A phase I trial of deep brain stimulation of memory circuits in Alzheimer's disease. Ann Neurol (2010) 2.64
Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res (2005) 2.61
Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol (2008) 2.46
Harnessing neuroplasticity for clinical applications. Brain (2011) 2.45
MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol (2013) 2.37
Disease state prediction from resting state functional connectivity. Magn Reson Med (2009) 2.37
Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry (2010) 2.36
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) (2011) 2.34
BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron (2004) 2.29
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry (2002) 2.23
Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery (2003) 2.21
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol (2006) 2.18
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry (2007) 2.15
The subthalamic nucleus in the context of movement disorders. Brain (2003) 2.10
Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain (2009) 2.05
Highly cited works in neurosurgery. Part II: the citation classics. J Neurosurg (2010) 2.04
The FM/AM world is shaping the future of deep brain stimulation. Mov Disord (2014) 2.02
Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg (2003) 2.01
Bilateral globus pallidus stimulation for Huntington's disease. Ann Neurol (2004) 2.00
A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry (2008) 1.90
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry (2005) 1.85
Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry (2006) 1.84
Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry (2012) 1.83
Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord (2007) 1.82
Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses. Gastroenterology (2010) 1.80
Deep brain stimulation of the subcallosal cingulate gyrus for depression: anatomical location of active contacts in clinical responders and a suggested guideline for targeting. J Neurosurg (2009) 1.79
Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci (2011) 1.79
Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry (2012) 1.78
Chronic anterior thalamus stimulation for intractable epilepsy. Epilepsia (2002) 1.78
The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry (2010) 1.70
Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol (2011) 1.65
Highly cited works in neurosurgery. Part I: the 100 top-cited papers in neurosurgical journals. J Neurosurg (2010) 1.64
Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol (2009) 1.62
Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg (2002) 1.60
Stuck in a rut: rethinking depression and its treatment. Trends Neurosci (2010) 1.60
Direct visualization of deep brain stimulation targets in Parkinson disease with the use of 7-tesla magnetic resonance imaging. J Neurosurg (2010) 1.57
Deep brain stimulation: postoperative issues. Mov Disord (2006) 1.57
Human anterior cingulate cortex neurons encode cognitive and emotional demands. J Neurosci (2005) 1.54
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease. Proc Natl Acad Sci U S A (2014) 1.53
Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease. Arch Neurol (2012) 1.52
Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp Brain Res (2004) 1.51
Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am J Psychiatry (2008) 1.49
Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum Brain Mapp (2009) 1.48
Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci (2011) 1.47
Synchronized neuronal discharge in the basal ganglia of parkinsonian patients is limited to oscillatory activity. J Neurosci (2002) 1.47
Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region. Mov Disord (2010) 1.46
Neurostimulation for chronic noncancer pain: an evaluation of the clinical evidence and recommendations for future trial designs. J Neurosurg (2006) 1.46
Long-term hardware-related complications of deep brain stimulation. Neurosurgery (2002) 1.46
Motor cortical stimulation for parkinsonism in multiple system atrophy. Arch Neurol (2003) 1.45
α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol (2012) 1.42
Subthalamic nucleus stimulation: improvements in outcome with reprogramming. Arch Neurol (2006) 1.42
A narrative history of the International Society for Psychiatric Surgery: 1970-1983. Stereotact Funct Neurosurg (2012) 1.40
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
Defining the neural circuitry of depression: toward a new nosology with therapeutic implications. Biol Psychiatry (2007) 1.39
Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurg (2004) 1.37
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry (2009) 1.33
The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. J Neurosurg (2008) 1.33
Functional convergence of developmentally and adult-generated granule cells in dentate gyrus circuits supporting hippocampus-dependent memory. Hippocampus (2010) 1.31
Neuromodulation for treatment-refractory major depressive disorder. CMAJ (2013) 1.29
An fMRI study investigating cognitive modulation of brain regions associated with emotional processing of visual stimuli. Neuropsychologia (2003) 1.29
State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry (2003) 1.28
Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery (2005) 1.24
Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5). PLoS One (2011) 1.21
Neurogenic hippocampal targets of deep brain stimulation. J Comp Neurol (2011) 1.19
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci (2009) 1.16
Pallidal neuronal activity: implications for models of dystonia. Ann Neurol (2003) 1.14
Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients. Neurology (2013) 1.14
Academic impact and rankings of American and Canadian neurosurgical departments as assessed using the h index. J Neurosurg (2010) 1.14
Bilateral pallidal stimulation in cervical dystonia: blinded evidence of benefit beyond 5 years. Brain (2013) 1.14
Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness. CNS Drugs (2010) 1.14
Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum Brain Mapp (2009) 1.13
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord (2009) 1.12
Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor. Neurology (2003) 1.12
Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol (2009) 1.12